• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

AstraZeneca’s Fasenra asthma drug shows promise for COPD treatment

cafead

Administrator
Staff member
  • cafead   May 21, 2024 at 11:42: AM
via AstraZeneca's Fasenra (benralizumab) has recently been approved by the FDA for treating severe asthma in children aged 6 to 11 with the eosinophilic phenotype. A phase III clinical trial is now underway to test the effectiveness of Fasenra in COPD.

article source
 

<